Skip to main content
Livermore
Livermore
ZHEN

Benjamin Edwards Inc

SEC CIK
0001451623
Latest filing
Jul 24, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Benjamin Edwards Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
54,488
Value
$2.97M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CRSP by Benjamin Edwards Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202654,488$2.97M<0.1%−1,018−1.8%ReducedHolders
Q1 202655,506$2.64M<0.1%+870+1.6%AddedHolders
Q4 202554,636$2.87M<0.1%+416+0.8%AddedHolders
Q3 202554,220$3.51M<0.1%−3,540−6.1%ReducedHolders
Q2 202557,760$2.81M<0.1%+6,845+13.4%AddedHolders
Q1 202550,915$1.73M<0.1%+5,853+13.0%AddedHolders
Q4 202445,062$1.77M<0.1%+12,359+37.8%AddedHolders
Q3 202432,703$1.54M<0.1%+32,465+13,640.8%AddedHolders
Q2 2024238$13.0K<0.1%−131−35.5%ReducedHolders
Q1 2024369$25.0K<0.1%+30+8.8%AddedHolders
Q4 2023339$21.0K<0.1%−165−32.7%ReducedHolders
Q3 2023504$23.0K<0.1%+13+2.6%AddedHolders
Q2 2023491$28.0K<0.1%−67−12.0%ReducedHolders
Q1 2023558$25.0K<0.1%+30+5.7%AddedHolders
Q4 2022528$21.0K<0.1%+107+25.4%AddedHolders
Q3 2022421$28.0K<0.1%−78−15.6%ReducedHolders
Q2 2022499$30.0K<0.1%+19+4.0%AddedHolders
Q1 2022480$30.0K<0.1%+10+2.1%AddedHolders
Q4 2021470$36.0K<0.1%+74+18.7%AddedHolders
Q3 2021396$44.0K<0.1%−14−3.4%ReducedHolders
Q2 2021410$66.0K<0.1%−68−14.2%ReducedHolders
Q1 2021478$58.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.